Code | 75039 | ||||||||||
MA number | 15/0118/83-CS | ||||||||||
Product Form: | plo ijf 1x1 g (liek.inj.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 17.05.1983 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_CEFOBID IM_IV 1 g _09.2023.pdf |
SPC: | SPC_CEFOBID IM_IV 1 g _09.2023.pdf |
Safety feature | Yes |
Data update: | 16.04.2018 |